ElizabethAnn(Wyer)GrosenMD

PubMed

• 61 citations
  Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
  Rodney P. Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. Chan, Minal A. Barve, Jonathan Oh, Devansu Tewari, Peter C. Morris, Erin E. Stevens, Justin N. Bott...> ;The Lancet. Oncology. 2020 Dec 1
• 69 citations
  Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.
  Jonathan Oh, Minal A. Barve, Carolyn M. Matthews, E. Colin Koon, Thomas P. Heffernan, Bruce Fine, Elizabeth A. Grosen, Melanie K. Bergman, Evelyn Fleming, Leslie R. De...> ;Gynecologic Oncology. 2016 Dec 1
• 15 citations
  Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologi...
  Robert A. Burger, Kathleen M. Darcy, Philip J. Disaia, Bradley J. Monk, Elizabeth A. Grosen, Tetsuya Gatanaga, Gale A. Granger, Jianmin Wang, Chunqiao Tian, Parviz Han...> ;Cancer. 2004 Jul 1
• 9 citations
  Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2.
  Ellen M. Hartenbach, Joanne M. Becker, Elizabeth A. Grosen, Howard H. Bailey, Daniel G. Petereit, Renata Laxova, Julian C. Schink> ;Genetic Testing. 2002 Jan 1
• 41 citations
  HUMAN UTERINE AND OVARIAN EXPRESSION OF GROWTH HORMONE-RELEASING HORMONE MESSENGER RNA IN BENIGN AND MALIGNANT GYNECOLOGIC CONDITIONS
  Omid Khorram, Mark A. Garthwaite, Elizabeth Grosen, Ted Golos> ;Fertility and Sterility. 2001 Jan 1
• 92 citations
  An individualized intervention to overcome patient‐related barriers to pain management in women with gynecologic cancers
  Sandra E. Ward, Heidi S. Donovan, Brenda Owen, Elizabeth Grosen, Ronald C. Serlin> ;Research in Nursing & Health. 2000 Oct 1
• 20 citations
  Paclitaxel hypersensitivity reactions related to bee-sting allergy
  Elizabeth Grosen, Evelyn Larrison, Cynthia Tiggelaar, Ellen Roecker> ;Lancet. 2000 Jan 22
• What is the diagnostic workup after biopsy of adenocarcinoma in situ during and after pregnancy
  Elizabeth Grosen, Kevin D. Benson, Jerome H. Gundersen> ;Journal of Lower Genital Tract Disease. 1999 Oct 1
• 8 citations
  An experience with estrogen replacement therapy in breast cancer survivors.
  Philip J. DiSaia, Elizabeth A. Grosen, Kathleen F. McGonigle, Julie L. Kuykendall, William T. Creasman, Wendy R. Brewster> ;International Journal of Fertility and Women's Medicine. 1999 Jun 1
• Clinical question: ask the experts.
  Elizabeth Grosen> ;Journal of Lower Genital Tract Disease. 1998 Oct 1
• 3 citations
  Pregnancy-related fibroadenoma of ectopic breast tissue in the vulva.
  Elina T. Xanos, Denise A. Kennedy, Elizabeth Grosen> ;Journal of Lower Genital Tract Disease. 1997 Jul 1
• 69 citations
  Hormone replacement therapy in breast cancer survivors: A cohort study ☆ ☆☆ ★
  Philip J. DiSaia, Elizabeth A. Grosen, Tom Kurosaki, Maureen Gildea, Beth Cowan, Hoda Anton-Culver> ;American Journal of Obstetrics and Gynecology. 1996 May 1
• 19 citations
  Replacement therapy for breast cancer survivors. A pilot study
  Philip J. Disaia, Elizabeth A. Grosen, Franco Odicino, Beth Cowan, Sergio Pecorelli, Alan G. Wile, William T. Creasman> ;Cancer. 1995 Nov 15
• 20 citations
  Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma.
  Robert A. Burger, Elizabeth A. Grosen, Gene R. Ioli, Marc E. Van Eden, Minha Park, Michael L. Berman, Alberto Manetta, Philip J. DiSaia, Gale A. Granger, Tetsuya Gatanaga> ;Journal of Interferon & Cytokine Research. 1995 Mar 1
• 9 citations
  Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian car...
  Robert A. Burger, Elizabeth A. Grosen, Gene R. Ioli, M E Van Eden, H D Brightbill, M. Gatanaga, P.J. DiSaia, Gale A. Granger, Tetsuya Gatanaga> ;Gynecologic Oncology. 1994 Nov 1
• 7 citations
  Release of soluble TNF/LT receptors from a human ovarian tumor cell line (PA-1) by stimulation with cytokines in vitro.
  M. Gatanaga, Elizabeth A. Grosen, Robert A. Burger, Gale A. Granger, Tetsuya Gatanaga> ;Lymphokine and Cytokine Research. 1993 Aug 1
• 21 citations
  Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy.
  Elizabeth A. Grosen, Gale A. Granger, M. Gatanaga, Elizabeth K. Ininns, Chenduen Hwang, Philip J. DiSaia, Michael L. Berman, Alberto Manetta, Dennis Emma, Tetsuya Gata...> ;Gynecologic Oncology. 1993 Jul 1
• 6 citations
  Blocking factors (soluble membrane receptors) for tumor necrosis factor and lymphotoxin detected in ascites and released in short-term cultures obtained from ascites a...
  Elizabeth A. Grosen, Robert S. Yamamoto, Gene R. Ioli, Elizabeth K. Ininns, M. Gatanaga, Tetsuya Gatanaga, P.J. DiSaia, M L Berman, Alberto Manetta, Gale A. Granger> ;Lymphokine and Cytokine Research. 1992 Dec 1
• 10 citations
  Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.
  Fabio Cappuccini, Robert S. Yamamoto, Philip J. DiSaia, Elizabeth A. Grosen, M. Gatanaga, Joseph A. Lucci, Elizabeth K. Ininns, Tetsuya Gatanaga, Gale A. Granger> ;Lymphokine and Cytokine Research. 1991 Jun 1
• 11 citations
  Mesenteric artery embolization by an unsuspected aortic tumor: diagnostic evaluation and operative management.
  Daniel P. Guyton, Elizabeth Grosen, Ghassan Al‐Moasses, Bernard Archer, Charles York, Modesto Peralta, Helmut Schreiber, Philip Foulis> ;Journal of Surgical Oncology. 1987 Nov 1
• 34 citations
  A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer.
  A.M. Westermann, E. Grosen, Dörthe M. Katschinski, Dirk Jäger, R. C. Rietbroek, Julian C. Schink, C L Tiggelaar, Elke Jäger, P. J. Zum Vörde Sive Vörding, A Neuman, Al...> ;European Journal of Cancer. 2001 Jun 1
• Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.
  Hartenbach, E. M., Harris, L. S., Bailey, H. H., Grosen, E. A., Larrison, E., Chen, D., Twiggs, L. B., Schink, J. C.> ;Cancer J Sci Am. 1999 Nov 01
• 1 citations
  Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases.
  H. I. Robins, E. Grosen, D M Katschinski, Walter L. Longo, C L Tiggelaar, Kutz M, J Winawer, Graziano Fm> ;The Journal of Rheumatology. 1999 Dec 1
• 6 citations
  A pilot study of melphalan, tumor necrosis factor-α and 41.8 °C whole-body hyperthermia
  H. I. Robins, Dörthe M. Katschinski, Walter L. Longo, E. Grosen, George Wilding, W. Gillis, C. Kraemer, C L Tiggelaar, D. Rushing, James A. Stewart, David R. Spriggs, ...> ;Cancer Chemotherapy and Pharmacology. 1999 Jan 1
• 9 citations
  Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.
  H. I. Robins, F. D'oleire, E. Grosen, David R. Spriggs> ;Anticancer Research. 1997 Jul 1
• Join now to see all